Kallum Titchmarsh
Stock Analyst at Morgan Stanley
(3.40)
# 2,391
Out of 4,609 analysts
192
Total ratings
47.7%
Success rate
5.9%
Average return
Main Sectors:
Stocks Rated by Kallum Titchmarsh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CTKB Cytek Biosciences | Maintained: Hold | $5.5 | $4.18 | +31.58% | 3 | Aug 6, 2026 | |
| A Agilent Technologies | Maintained: Buy | $160 | $141.11 | +13.39% | 6 | Aug 5, 2026 | |
| WAT Waters | Maintained: Hold | $390 → $430 | $400.00 | +7.50% | 5 | Aug 5, 2026 | |
| STVN Stevanato Group | Rated: Hold | $19 → $20 | $20.10 | -0.50% | 10 | Aug 5, 2026 | |
| MTD Mettler-Toledo International | Rated: Hold | $1,275 → $1,450 | $1,421.52 | +2.00% | 5 | Aug 4, 2026 | |
| VCYT Veracyte | Rated: Sell | $47 → $44 | $46.15 | -4.66% | 6 | Aug 4, 2026 | |
| GH Guardant Health | Rated: Buy | $175 → $185 | $163.18 | +13.37% | 7 | Aug 4, 2026 | |
| DHR Danaher | Maintained: Buy | $220 | $199.66 | +10.19% | 9 | Aug 3, 2026 | |
| AVTR Avantor | Maintained: Hold | $10 → $14 | $13.36 | +4.79% | 2 | Jul 30, 2026 | |
| ADPT Adaptive Biotechnologies | Maintained: Hold | $20 → $22 | $24.60 | -10.57% | 5 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $200 → $240 | $236.05 | +1.67% | 6 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $37 | $47.46 | -22.04% | 6 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $620 → $650 | $577.83 | +12.49% | 5 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 | $46.70 | +49.89% | 5 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $185 → $260 | $260.72 | -0.28% | 6 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $325 → $365 | $351.02 | +3.98% | 9 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $250 → $310 | $274.62 | +12.88% | 5 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $9 → $13 | $13.52 | -3.85% | 4 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $18.56 | +2.37% | 2 | Jun 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $35 | $27.17 | +28.82% | 1 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $60 | $74.18 | -19.12% | 5 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 → $68 | $80.54 | n/a | 6 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $200 → $182 | $60.09 | n/a | 12 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $130 → $160 | $124.50 | n/a | 15 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 → $15 | $3.57 | n/a | 11 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 | $4.78 | n/a | 3 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $18.04 | n/a | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $260 | $323.21 | n/a | 12 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 → $11 | $9.57 | n/a | 4 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 → $4 | $5.55 | n/a | 14 | Dec 3, 2024 |
Cytek Biosciences
Aug 6, 2026
Maintained: Hold
Price Target: $5.5
Current: $4.18
Upside: +31.58%
Agilent Technologies
Aug 5, 2026
Maintained: Buy
Price Target: $160
Current: $141.11
Upside: +13.39%
Waters
Aug 5, 2026
Maintained: Hold
Price Target: $390 → $430
Current: $400.00
Upside: +7.50%
Stevanato Group
Aug 5, 2026
Rated: Hold
Price Target: $19 → $20
Current: $20.10
Upside: -0.50%
Mettler-Toledo International
Aug 4, 2026
Rated: Hold
Price Target: $1,275 → $1,450
Current: $1,421.52
Upside: +2.00%
Veracyte
Aug 4, 2026
Rated: Sell
Price Target: $47 → $44
Current: $46.15
Upside: -4.66%
Guardant Health
Aug 4, 2026
Rated: Buy
Price Target: $175 → $185
Current: $163.18
Upside: +13.37%
Danaher
Aug 3, 2026
Maintained: Buy
Price Target: $220
Current: $199.66
Upside: +10.19%
Avantor
Jul 30, 2026
Maintained: Hold
Price Target: $10 → $14
Current: $13.36
Upside: +4.79%
Adaptive Biotechnologies
Jul 30, 2026
Maintained: Hold
Price Target: $20 → $22
Current: $24.60
Upside: -10.57%
Jul 29, 2026
Maintained: Hold
Price Target: $200 → $240
Current: $236.05
Upside: +1.67%
Jul 27, 2026
Maintained: Hold
Price Target: $37
Current: $47.46
Upside: -22.04%
Jul 24, 2026
Maintained: Buy
Price Target: $620 → $650
Current: $577.83
Upside: +12.49%
Jul 10, 2026
Maintained: Buy
Price Target: $70
Current: $46.70
Upside: +49.89%
Jul 9, 2026
Rated: Buy
Price Target: $185 → $260
Current: $260.72
Upside: -0.28%
Jul 9, 2026
Rated: Hold
Price Target: $325 → $365
Current: $351.02
Upside: +3.98%
Jul 9, 2026
Rated: Buy
Price Target: $250 → $310
Current: $274.62
Upside: +12.88%
Jul 9, 2026
Rated: Hold
Price Target: $9 → $13
Current: $13.52
Upside: -3.85%
Jun 5, 2026
Maintained: Buy
Price Target: $19
Current: $18.56
Upside: +2.37%
May 15, 2026
Maintained: Hold
Price Target: $35
Current: $27.17
Upside: +28.82%
May 12, 2026
Maintained: Hold
Price Target: $60
Current: $74.18
Upside: -19.12%
Jul 15, 2025
Maintained: Buy
Price Target: $100 → $68
Current: $80.54
Upside: n/a
Jul 15, 2025
Maintained: Buy
Price Target: $200 → $182
Current: $60.09
Upside: n/a
Jun 11, 2025
Maintained: Buy
Price Target: $130 → $160
Current: $124.50
Upside: n/a
May 20, 2025
Maintained: Hold
Price Target: $20 → $15
Current: $3.57
Upside: n/a
May 9, 2025
Maintained: Hold
Price Target: $10
Current: $4.78
Upside: n/a
May 6, 2025
Reiterated: Buy
Price Target: $19
Current: $18.04
Upside: n/a
Apr 24, 2025
Maintained: Hold
Price Target: $260
Current: $323.21
Upside: n/a
Feb 27, 2025
Maintained: Hold
Price Target: $10 → $11
Current: $9.57
Upside: n/a
Dec 3, 2024
Maintained: Hold
Price Target: $5 → $4
Current: $5.55
Upside: n/a